SCHEMBL2470872

SCHEMBL2470872

Cc1onc(-c2ccccc2)c1-c1cn(-c2ncccn2)c(COCc2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.47
TDP1 Q9NUW8 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
PTGS1 P23219 3/20 0.44
PTGS2 P35354 3/20 0.44
GABRA5 P31644 6/20 0.42
MAPK14 Q16539 2/20 0.42
MAPK8 P45983 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
KMT2A Q03164 1/20 0.36
KCNH2 Q12809 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
HTT P42858 1/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CA12 O43570 1/20 0.36
MT-CO2 P00403 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2469050 0.89 MAPT (0.46) MAPTTDP1L3MBTL1PTGS1PTGS2
SCHEMBL2472364 0.83 GABRA5 (0.43) MAPTTDP1L3MBTL1PTGS1PTGS2
SCHEMBL2468947 0.83 MAPT (0.46) MAPTTDP1L3MBTL1PTGS1PTGS2
SCHEMBL2470840 0.82 GABRA5 (0.43) MAPTTDP1L3MBTL1PTGS1PTGS2
SCHEMBL2472255 0.82 PTGS2 (0.52) MAPTTDP1L3MBTL1PTGS1PTGS2
SCHEMBL2470784 0.82 MAPK14 (0.42) MAPTTDP1L3MBTL1PTGS1PTGS2
SCHEMBL2472135 0.81 GABRA5 (0.44) MAPTTDP1L3MBTL1PTGS1PTGS2
SCHEMBL2470549 0.78 GABRA5 (0.42) MAPTTDP1L3MBTL1PTGS1PTGS2
SCHEMBL2474321 0.77 MAPT (0.41) MAPTTDP1L3MBTL1PTGS1PTGS2
SCHEMBL2469049 0.77 GABRA5 (0.42) MAPTTDP1L3MBTL1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968973-B1 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2011-10-05 EP claimed
EP-1968973-A2 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2008-09-17 EP claimed
US-7414061-B2 Aryl-isoxazol-4-yl-imidazole derivatives HOFFMANN-LA ROCHE INC. (US) 2008-08-19 US claimed
US-20070161654-A1 Aryl-isoxazol-4-yl-imidazole derivatives HOFFMANN-LA ROCHE INC. 2007-07-12 US claimed
WO-2007074078-A2 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-07-05 WO claimed
EP-1968973-B1 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2011-10-05 EP disclosed
EP-1968973-A2 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2008-09-17 EP disclosed
US-7414061-B2 Aryl-isoxazol-4-yl-imidazole derivatives HOFFMANN-LA ROCHE INC. (US) 2008-08-19 US disclosed
US-20070161654-A1 Aryl-isoxazol-4-yl-imidazole derivatives HOFFMANN-LA ROCHE INC. 2007-07-12 US disclosed
WO-2007074078-A2 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161654-A1 Aryl-isoxazol-4-yl-imidazole derivatives GABRA5, GABRA4, GABRA1 MAPT 254/4885TDP1 3176/4885L3MBTL1 3361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.